Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: Sonny who wrote (103)	10/8/1998 3:44:00 PM
From: Lel H	Read Replies (1) \| Respond to of 1834

This company's stock price movement is strange, especially today. If I had more time and patience, I would try to actively trade it, but I'm such a lousy market timer.

To: Sonny who wrote (103)	3/3/1999 7:56:00 PM
From: Sonny	Respond to of 1834

I'm all excited about the fact that now we have a real chance of curing glioblastoma. Its all UP from here imho! Those who wait, will also be rewarded, albeit a bit less ... by the time all the variables are out and its clear sailing towards manufacturing a drug, the stock price might be in 50 to 75 range! I like the favorable R/R ratio here. All the partnerships are in place, foundation is solid, cash is good, energies are parallely spent on multiple channels to increase the probability of a jackpot run! :-) regards to all, -/Sonny.